Sign in

CIK 0001869105 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

BridgeBio Oncology Therapeutics, Inc.

Sign in to watch
Ticker
BBOT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
857 702 0377
Business address
256 E. GRAND AVENUE, SUITE 104, SOUTH SAN FRANCISCO, CA, 94080
Former names
Helix Acquisition Corp. II
  1. S-3 Offering Registration Statement
  2. 424B3 Offering Prospectus
  3. 424B3 Offering Prospectus
  4. 424B3 Offering Prospectus
  5. 424B3 Offering Prospectus
  6. 424B3 Offering Prospectus
  7. 424B3 Offering Prospectus
  8. 424B3 Offering Prospectus
  9. 424B3 Offering Prospectus
  10. 424B3 Offering Prospectus
  11. 424B3 Offering Prospectus
  12. 424B3 Offering Prospectus
  13. CORRESP Other Correspondence Between Filers and SEC Staff
  14. UPLOAD Other SEC-generated Letter
  15. S-1 Offering Registration Statement
  16. 424B3 Offering Prospectus
  17. 424B4 Offering Prospectus
  18. CORRESP Other Correspondence Between Filers and SEC Staff
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. UPLOAD Other SEC-generated Letter

Page 1 of 2 · 35 filings